Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,942.71 +2,163.59 (+3.50%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Cidara Therapeutics, Inc. (CDTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 57.07M |
| Enterprise value | 26.17M |
| Trailing P/E | N/A |
| Forward P/E | 5.75 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.86 |
| Price/book (mrq) | 14.69 |
| Enterprise value/revenue | 0.41 |
| Enterprise value/EBITDA | -1.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | -40.19% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 29.60 |
| 52-week low 3 | 10.00 |
| 50-day moving average 3 | 15.08 |
| 200-day moving average 3 | 16.28 |
Share statistics
| Avg vol (3-month) 3 | 60.69k |
| Avg vol (10-day) 3 | 194.9k |
| Shares outstanding 5 | 4.56M |
| Implied shares outstanding 6 | 4.58M |
| Float 8 | 3.88M |
| % held by insiders 1 | 7.34% |
| % held by institutions 1 | 30.25% |
| Shares short (15 Apr 2024) 4 | 8.17k |
| Short ratio (15 Apr 2024) 4 | 0.15 |
| Short % of float (15 Apr 2024) 4 | 0.18% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.18% |
| Shares short (prior month 15 Mar 2024) 4 | 8.97k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 24 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -35.88% |
| Operating margin (ttm) | -34.54% |
Management effectiveness
| Return on assets (ttm) | -26.72% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 63.91M |
| Revenue per share (ttm) | 14.62 |
| Quarterly revenue growth (yoy) | 69.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -24.37M |
| Net income avi to common (ttm) | -22.93M |
| Diluted EPS (ttm) | -5.20 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 35.78M |
| Total cash per share (mrq) | 7.84 |
| Total debt (mrq) | 4.88M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.90 |
| Book value per share (mrq) | -1.81 |
Cash flow statement
| Operating cash flow (ttm) | -22.43M |
| Levered free cash flow (ttm) | 664.12k |
© 2024 Yahoo. All rights reserved.